Identifying a mechanism responsible for altering microbial communities opens the door to the development of new therapies designed to interrupt the chain of events that give these pathogens a growth advantage after antibiotic treatments, the researchers said.
"Research has traditionally focused on the mechanisms by which antibiotics help control the growth of bacteria or inform the development of new formulations when bacteria become resistant to existing drugs," said Franziska Faber, from the University of California, Davis (UC Davis).
Gastroenteritis is a common side effect of taking antibiotics.
While diarrhoea may be mild and clear up after antibiotic therapy is completed, in some cases, it can lead to colitis, an inflammation of the colon, or more serious conditions that cause abdominal pain, fever and bloody diarrhoea.
Also Read
Researchers found that oral antibiotic treatment increased the synthesis of a host enzyme that generates nitric oxide radicals, which can oxidise sugars into sugar acids, such as galactarate, a key driver of Salmonella growth.
"The new study suggests that this property is part of a 'business plan' Salmonella uses to grow in the host intestine," he said.
The study was published in the journal Nature.